Kinnos, a New York-based maker of technology that colorizes disinfectants to improve the quality of disinfection, raised additional $15M in funding.
Current and new investors included family offices and funds like Pioneer Healthcare Partners, Kapor Center, and Partnership Fund for NYC and former industry leaders from Abbott, Baxalta, Baxter, Bayer, Becton Dickinson, Cantel, Ecolab, Intermountain Healthcare, NorthShore University HealthSystem, and Walgreens, among others.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Steve Fanning, Kinnos provides Highlight, which temporarily colors disinfectant wipes and cleaning solutions that hospitals already use to provide staff with an instantaneous visual cue to improve the quality of disinfection. It is already in use by hospitals, first responders, and transit agencies around the world.
FinSMEs
02/05/2023